Loading data
JCINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 23.6 bn USD | 22.95 bn USD | 22.33 bn USD | 20.64 bn USD |
| Cost of revenue | 15 bn USD | 14.88 bn USD | 14.53 bn USD | 13.55 bn USD |
| Gross profit | 8.59 bn USD | 8.08 bn USD | 7.8 bn USD | 7.09 bn USD |
| Research and development expense | 273 m USD | 267 m USD | 251 m USD | 236 m USD |
| Selling, general and administrative expense | 5.76 bn USD | 5.66 bn USD | 5.39 bn USD | 5.08 bn USD |
| Interest expense | — | — | — | 225 m USD |
| Profit before tax | 1.97 bn USD | 1.52 bn USD | 1.11 bn USD | 1.11 bn USD |
| Income tax expense | 245 m USD | 111 m USD | -468 m USD | -182 m USD |
| Net income (reported basis) | 3.29 bn USD | 1.71 bn USD | 1.85 bn USD | 1.53 bn USD |
| Basic earnings per share | 5.04 USD/share | 2.53 USD/share | 2.7 USD/share | 2.2 USD/share |
| Diluted earnings per share | 5.03 USD/share | 2.52 USD/share | 2.69 USD/share | 2.19 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.